TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 0 | -2 | -21 | -28 | -46 | -50 | -29 |
| S | %wins | 50 | 100 | 100 | 100 | 100 | 100 | 92 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/14/04 20:29 | 4/5/04 | DSCO | Discovery Laboratories Inc /de/ | DE | Health | BioPrd | Biological Products, (No Diag | Davis Cynthia | PA | O | VP,Contr | M.ad | 21 | 1.38 | 0 | 15 | 260 | 21 | D | 607 | 66 | 15 | 1 | 19 | -1 | 0 | 1 | 0 | -17 | -27 | -42 | -48 | |
4/14/04 20:29 | 4/5/04 | DSCO | Discovery Laboratories Inc /de/ | DE | Health | BioPrd | Biological Products, (No Diag | Davis Cynthia | PA | O | VP,Contr | S.ad | -189 | 12.61 | 0 | -15 | -42 | 21 | D | 607 | 66 | 15 | 1 | 19 | -1 | 0 | 1 | 0 | -17 | -27 | -42 | -48 | |
4/12/04 17:37 | 4/8/04 | DSCO | Discovery Laboratories Inc /de/ | DE | Health | BioPrd | Biological Products, (No Diag | Davis Cynthia | PA | O | VP,Contr | M.d | 21 | 1.38 | 0 | 15 | 260 | 21 | D | 588 | 60 | 20 | 4 | 8 | 9 | -2 | -1 | -3 | -24 | -29 | -50 | -51 | |
4/12/04 17:37 | 4/8/04 | DSCO | Discovery Laboratories Inc /de/ | DE | Health | BioPrd | Biological Products, (No Diag | Davis Cynthia | PA | O | VP,Contr | S.d | -189 | 12.61 | 0 | -15 | -42 | 21 | D | 588 | 60 | 20 | 4 | 8 | 9 | -2 | -1 | -3 | -24 | -29 | -50 | -51 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |